홈 › 직장암 › 뉴욕 › New York City
NY New York City의 직장암 임상 시험
직장암 관련 연구 17개가 New York City 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
피험자 모집 중3상
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
피험자 모집 중2상
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
피험자 모집 중1/2상
- NYU Langone Health Perlmutter Cancer Center, New York
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
피험자 모집 중2상
- Memorial Sloan Kettering Cancer Center, New York
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
피험자 모집 중
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
피험자 모집 중2상
- Weill Cornell Medical College, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
피험자 모집 중3상
- Memorial Sloan Kettering Cancer Center, New York
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
피험자 모집 중
- Weill Cornell Medical College, New York
- New York Presbyterian Hospital - Queens, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
피험자 모집 중1/2상
- NYU Langone Medical Center, New York
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
피험자 모집 중
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
피험자 모집 중1상
- Columbia University Irving Medical Center, New York
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
피험자 모집 중2상
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
피험자 모집 중관찰 연구
- Memorial Sloan Kettering Cancer Center, New York
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
피험자 모집 중2상
- Columbia University Irving Medical Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
피험자 모집 중1/2상
- NYU Langone Health, New York
다른 도시의 직장암 시험
- Boston, MA연구 12개
- Houston, TX연구 11개
- St. Louis, MO연구 11개
- Columbus, OH연구 10개
- Los Angeles, CA연구 10개
- Tampa, FL연구 9개
- Seattle, WA연구 9개
- Nashville, TN연구 9개
- Baldwin Park, CA연구 8개
- Salt Lake City, UT연구 8개
- Aurora, CO연구 8개
- Philadelphia, PA연구 8개
New York City의 다른 연구
- 유방암연구 136개
- 비소세포폐암연구 121개
- 암 (전체)연구 109개
- 전립선암연구 103개
- 전이성 암연구 93개
- 대장직장암연구 78개
- 난소암연구 69개
- 폐암연구 60개
- 다발성 골수종연구 60개
- 췌장암연구 60개
- 자궁내막암연구 52개
- 급성 골수성 백혈병연구 51개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.